Pharmaceutical API Raw Powder Dasatinib CAS 302962-49-8

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: Frazer-Dasatinib
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: White Powder
• Purity: >99%
• Appearance: White Powder
• Shelf Life: 2 Years
• Storage: Keep in Cool and Dry Place
• Delivery: Express 5-7 Days Arrive
• Test Method: HPLC
• Assay: 99%
• MOQ: 1kg
• Shipping Area: Worldwide/All Countries
• CAS: 302962-49-8
• Service: Good Service
• Delivery Method: FedEx/DHL/Special Line
• Mf: C22h28cln7o3s
• Transport Package: Foil Bag
• Specification: 99%
• Trademark: Xi′an Frazer Biotech Co., Ltd.
• Origin: China
• Production Capacity: 200kg Per Month

Product Description

Pharmaceutical API Raw Powder Dasatinib CAS 302962-49-8

 

Specification of Analysis

Items	Standard	Result
Appearance	White to off-white powder	off-white powder
Assay	99%min	99.81%
Loss on drying	≤1.0%	0.65%
Residue on Ignition	≤0.1%	0.05%
Heavy metals	≤10ppm	Conforms
Related Substance	Single impurity≤0.1%	0.07%
	Total Impurities≤1.0%	0.12%
Conclusion	Conform to the Enterprise Standards

lntroduce:

Dasatinib is a cancer medicine that slows the growth and spread of cancer cells in the body. Dasatinib, previously known as BMS-354825, Dasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first line use in patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

Functions
Dasatinib is used to treat chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) when other cancer treatments have not been effective.

Applications
Dasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitorapproved for first line use in patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia.